Can cystatin C clarify eGFR when creatinine is affected by age, sex, body size, or muscle mass?

Standard creatinine-based estimated glomerular filtration rate (eGFRcr) is highly sensitive to non-renal factors, often necessitating alternative biomarkers to ensure diagnostic accuracy.

Limitations of creatinine-based estimates

• Demographic and muscle bias: Creatinine is an endogenous byproduct of skeletal muscle metabolism. Standard equations use age and sex as surrogates for muscle mass. However, they cannot account for individual variations in muscle volume, which is highly relevant when assessing patients with atypical body compositions.
• Systematic errors: In individuals with low muscle mass, sarcopenia, or cachexia, reduced creatinine generation causes a systematic overestimation of kidney function, which can dangerously mask underlying chronic kidney disease (CKD). Conversely, highly muscular individuals frequently present with falsely underestimated eGFRcr.
• Body size indexing: Standard clinical reporting normalizes eGFR to a body surface area (BSA) of 1.73 m². In individuals at the extremes of body size, this indexing distorts clinical estimates, understating filtration in larger individuals and overstating it in smaller individuals.

Role of cystatin C and combined equations

• Resolving discordance: Discrepancies between creatinine- and cystatin C-based filtration estimates are common, occurring in 25% to 40% of patients. Because cystatin C is produced by all nucleated cells and is independent of muscle mass, it serves as an effective corrective marker.
• Enhanced accuracy: The KDIGO 2024 clinical practice guidelines recommend utilizing the combined creatinine-cystatin C equation (eGFRcr-cys) to resolve discordances. This combined approach minimizes systematic bias and closely aligns with gold-standard measured GFR (mGFR) clearance testing using iohexol or iothalamate.

Bottom line

• Creatinine-based eGFR is frequently confounded by muscle mass, age, and body size; measuring cystatin C—specifically within a combined eGFRcr-cys equation—clarifies true renal filtration and prevents the misstaging of kidney disease.